Hypoactive Sexual Desire Disorder (HSDD)

Characteristics and diagnostic features

HSDD can present in different patterns. Common clinical distinctions include:

• Lifelong — low desire present since the person first became sexually active.
• Acquired — desire was previously typical but decreased or disappeared.
• Generalized — low desire in all situations and with all partners.
• Situational — low desire limited to certain relationships or circumstances.

Assessment typically involves a detailed history of sexual function, mood, relationship dynamics and medication use. Brief screening tools such as the Decreased Sexual Desire Screener are used in clinical practice. For formal diagnostic criteria and guidance see diagnostic resources.

Causes and contributing factors

HSDD is a multifactorial condition. Contributing influences may include biological, psychological and social factors. Examples often considered during evaluation are:

• Medical and hormonal conditions (thyroid disease, menopause, chronic illness).
• Medications (certain antidepressants, antipsychotics, hormonal contraceptives among others).
• Mental health issues (depression, anxiety, past sexual trauma).
• Relationship problems (conflict, poor communication, mismatched desire).
• Stress, fatigue and lifestyle factors.

History and classification

The concept of markedly reduced sexual desire was described in clinical literature in the late 1960s and 1970s as interest in sexual dysfunction grew. Diagnostic language has changed over time: for example, the DSM-5 combined female HSDD with female sexual arousal disorder into a single category called female sexual interest/arousal disorder. Despite such changes, HSDD remains a widely used term in research and practice when focusing on diminished desire as the primary problem.

Treatment and management

Treatment is individualized and addresses the underlying contributors. Common approaches include:

• Psychotherapy and sex therapy (individual or couples work, cognitive-behavioural approaches, sensate focus exercises).
• Relationship counseling to improve communication and intimacy.
• Review and change of medications when appropriate.
• Medical or hormonal interventions in select cases; some medications have regulatory approval for premenopausal women with distressing low desire in some countries (discuss risks and benefits with a specialist).
• Lifestyle changes to reduce stress, improve sleep and address comorbid health problems.

Reliable treatment information and prescribing details can be found at reputable medical resources; for guidance on pharmacologic options see treatment resources.

Importance and notable distinctions

Distinguishing low sexual desire from normal variations in libido is essential: desire alone is not a disorder unless it causes significant distress or relationship harm. Clinicians evaluate medical, psychological and interpersonal factors and avoid attributing diminished desire solely to aging or partner characteristics. Early, comprehensive assessment improves the chance of effective, tailored treatment.